Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Grant/Award of 55,924 RNXT shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | RenovoRx, Inc. (RNXT) | Grant/Award | 55,924 | n/a |
| Mar 25, 2026 | RenovoRx, Inc. (RNXT) | Purchase | 9,720 | n/a |
| Oct 3, 2025 | RenovoRx, Inc. (RNXT) | Grant/Award | 47,640 | n/a |
| May 6, 2025 | RenovoRx, Inc. (RNXT) | Exercise/Conversion | 20,480 | $3.1K |
| Apr 10, 2025 | RenovoRx, Inc. (RNXT) | Purchase | 12,050 | $10.2K |
| Oct 2, 2024 | RenovoRx, Inc. (RNXT) | Grant/Award | 25,099 | n/a |
| Jan 30, 2024 | RenovoRx, Inc. (RNXT) | Purchase | 8,196 | n/a |
| Oct 2, 2023 | RenovoRx, Inc. (RNXT) | Grant/Award | 25,099 | n/a |
| Nov 4, 2022 | RenovoRx, Inc. (RNXT) | Exercise/Conversion | 25,438 | $43.2K |
| Oct 4, 2022 | RenovoRx, Inc. (RNXT) | Grant/Award | 25,099 | n/a |